	US 12,414,976 B2
	Pharmaceutical composition for preventing hair loss or promoting hair growth, comprising ginsenoside RG4 or mixture (Rgx 365) of ginsenosides Rg2, Rg4, Rg6, and Rh1 as active ingredient
Gyu Yong Song, Daejeon (KR); and Jee Hyun Lee, Daejeon (KR)
Assigned to AREZ CO., LTD., Daejeon (KR)
Appl. No. 17/622,541
Filed by AREZ CO., LTD., Daejeon (KR)
PCT Filed Jun. 23, 2020, PCT No. PCT/KR2020/008159 § 371(c)(1), (2) Date Dec. 23, 2021, PCT Pub. No. WO2020/262933, PCT Pub. Date Dec. 30, 2020.
Claims priority of application No. 10-2019-0075487 (KR), filed on Jun. 25, 2019.
Prior Publication US 2022/0354915 A1, Nov. 10, 2022
Int. Cl. A61K 36/258 (2006.01); A23L 33/105 (2016.01); A61K 8/60 (2006.01); A61P 17/14 (2006.01)

CPC A61K 36/258 (2013.01) [A23L 33/105 (2016.08); A61K 8/60 (2013.01); A61P 17/14 (2018.01)]

9 Claims

1. A method for preventing hair loss or promoting hair growth in a subject, comprising administering to the subject in need thereof an effective amount of the pharmaceutical composition of ginsenoside Rg4 and pharmaceutically acceptable carriers, and wherein the pharmaceutical composition comprises 30-40% by weight of ginsenoside Rg4.